These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 26012629)
1. Editorial Comment to Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era. Bigot P; Lebdai S; Azzouzi AR Int J Urol; 2015 Aug; 22(8):740-1. PubMed ID: 26012629 [No Abstract] [Full Text] [Related]
2. Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era. Tatsugami K; Shinohara N; Kondo T; Yamasaki T; Eto M; Tsushima T; Terachi T; Naito S; Int J Urol; 2015 Aug; 22(8):736-40. PubMed ID: 25988793 [TBL] [Abstract][Full Text] [Related]
5. The role and timing of cytoreductive nephrectomy in the immunotherapy era. Wong ECL; Kapoor A Eur Urol Focus; 2020 Jan; 6(1):7-8. PubMed ID: 30824380 [TBL] [Abstract][Full Text] [Related]
6. The use of cytoreductive nephrectomy in patients with renal cell carcinoma. Ghandour RA; Singla N; Margulis V Expert Rev Anticancer Ther; 2019 May; 19(5):405-411. PubMed ID: 31020871 [TBL] [Abstract][Full Text] [Related]
7. Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma Treated With Targeted Therapies: A Systematic Review With a Meta-Analysis. Petrelli F; Coinu A; Vavassori I; Cabiddu M; Borgonovo K; Ghilardi M; Lonati V; Barni S Clin Genitourin Cancer; 2016 Dec; 14(6):465-472. PubMed ID: 27138461 [TBL] [Abstract][Full Text] [Related]
8. Evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma of variant histology. Alhalabi O; Karam JA; Tannir NM Curr Opin Urol; 2019 Sep; 29(5):521-525. PubMed ID: 31305271 [TBL] [Abstract][Full Text] [Related]
9. The role of cytoreductive surgery in the era of targeted agents. Noe A; Stewart GD; Bex A Curr Opin Urol; 2015 Sep; 25(5):374-80. PubMed ID: 26075568 [TBL] [Abstract][Full Text] [Related]
10. Up-front Targeted Therapy Prior to Cytoreductive Nephrectomy in Treatment-Naive Patients With Metastatic Renal Cell Carcinoma. Agarwal N; Shuch B; Pal SK JAMA Oncol; 2016 Oct; 2(10):1273-1274. PubMed ID: 27254305 [No Abstract] [Full Text] [Related]
11. Editorial: The evolving role of cytoreductive nephrectomy. Singla N; Hakimi AA; Margulis V Curr Opin Urol; 2019 Sep; 29(5):505-506. PubMed ID: 31246591 [No Abstract] [Full Text] [Related]
12. Prognostic value of cytoreductive nephrectomy combined with targeted therapy for metastatic renal cell carcinoma: a meta-analysis. Hong X; Li F; Tang K; Pang S; Lin G; Li S; Bao J; Tan W Int Urol Nephrol; 2016 Jun; 48(6):967-75. PubMed ID: 26861063 [TBL] [Abstract][Full Text] [Related]
13. The evolving role of cytoreductive nephrectomy: incorporating genomics of metastatic renal cell carcinoma into treatment decisions. Mano R; Gopal N; Hakimi AA Curr Opin Urol; 2019 Sep; 29(5):531-539. PubMed ID: 31313716 [TBL] [Abstract][Full Text] [Related]
14. Cytoreductive nephrectomy in the era of targeted therapies: a review. Pindoria N; Raison N; Blecher G; Catterwell R; Dasgupta P BJU Int; 2017 Sep; 120(3):320-328. PubMed ID: 28371084 [TBL] [Abstract][Full Text] [Related]
15. A commentary on 'The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the targeted therapy and immunological therapy era: a systematic review and meta-analysis' [Int J Surg (2023) 109:982-994]. Wang Q; Shi H; Sun Y; Feng W; Xu H; Wang H Int J Surg; 2024 Apr; 110(4):2458-2459. PubMed ID: 38668669 [No Abstract] [Full Text] [Related]
16. Cytoreductive nephrectomy with thrombectomy before targeted therapy improves survival for metastatic renal cell carcinoma with venous tumor thrombus: a single-center experience. Qi N; Wu P; Chen J; Li T; Ning X; Wang J; Gong K World J Surg Oncol; 2017 Jan; 15(1):4. PubMed ID: 28056988 [TBL] [Abstract][Full Text] [Related]
17. Treatment strategies for advanced renal cell carcinoma: A new paradigm for surgical treatment. Tomita Y Int J Urol; 2016 Jan; 23(1):13-21. PubMed ID: 26347163 [TBL] [Abstract][Full Text] [Related]
18. Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End. Massari F; Di Nunno V; Santoni M; Gatto L; Mollica V; Porta C Eur Urol Oncol; 2019 Sep; 2(5):603-604. PubMed ID: 31411982 [No Abstract] [Full Text] [Related]
19. Analysis of pre-operative variables for identifying patients who might benefit from upfront cytoreductive nephrectomy for metastatic renal cell carcinoma in the targeted therapy era. You D; Jeong IG; Song C; Lee JL; Hong B; Hong JH; Ahn H; Kim CS Jpn J Clin Oncol; 2015 Jan; 45(1):96-102. PubMed ID: 25341544 [TBL] [Abstract][Full Text] [Related]
20. Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy: Scientifically Relevant or Natural Selection? Biswas B; Dabkara D; Ganguly S; Eswaran P; Ghosh J J Clin Oncol; 2017 Apr; 35(11):1265-1266. PubMed ID: 28165897 [No Abstract] [Full Text] [Related] [Next] [New Search]